Biomedical innovation alone is not sufficient to increase hepatitis C virus (HCV) treatment engagement among patients most marginalized, with sustainable resourcing of community services crucial in order to effect changes, a recent study found. This intervention from the HepCATT study comprised multiple components, including a nurse facilitator, peer support, and education initiatives. The 96 participants comprised drug service and intervention providers and clients with injecting history. Researchers found:
- Client engagement with a HCV treatment service rose from 16 at baseline in 2014 to 147 in 2016.
- Baseline testing and treatment barriers included limited HCV knowledge, fear of diagnosis and treatment, precarious living circumstances, and service-specific obstacles.
- Treatment engagement was aided by intervention timeliness, improved communication structures, personalized care, streamlined testing and treatment pathways, and peer support.
- The nurse practitioner was key to intervention success.
Harris M, Bonnington O, Harrison G, Hickman M, Irving W; on behalf of the HepCATT team. Understanding hepatitis C intervention success—Qualitative findings from the HepCATT study. [Published online ahead of print February 27, 2018]. J Viral Hepat. doi:10.1111/jvh.12869.
This Week's Must Reads
Relevance of Health Literacy to CV Health, Circulation; ePub 2018 Jun 4; Magnani, et al
Diabetes & Long-Term Kidney Disease, Diabetes Care; ePub 2018 Jun 1; Warren, et al
Maternal Loss of Control Over Eating, Am J Clin Nutr; ePub 2018 Jun 5; Micali, et al
Efficacy of Brief Behavioral Treatment for Insomnia, Sleep Medicine; ePub 2018 Jun 2; McCrae, et al
Opioid-Related Adverse Events in Surgical Patients, JAMA Surg; ePub 2018 May 23; Shafi, et al
Must Reads in Hepatitis
Glecaprevir/pibrentasvir Can Reduce HCV Tx Duration, Hepatol Int; ePub 2018 May 29; Abutaleb, et al
Estimates of HCV by Race and Sex in US, BMC Infect Dis; ePub 2018 May 16; Hall, et al
Efficacy of DAA Therapy for HCV in Older Adults, J Am Geriatr Soc; ePub 2018 May 25; Mazzarelli, et al
HCV Treatment in People Who Inject Drugs, Open Forum Infect Dis; ePub 2018 May 23; Alimohammadi, et al
Risk of HCV Among Vulnerable Populations, J Viral Hepat; ePub 2018 May 31; Aisyah, et al